2001 Legislation
Print Friendly

HOUSE BILL NO. 103 – Carisoprodol, Schedule IV

HOUSE BILL NO. 103

View Daily Data Tracking History

View Bill Text

View Statement of Purpose / Fiscal Impact



Text to be added within a bill has been marked with Bold and
Underline. Text to be removed has been marked with
Strikethrough and Italic. How these codes are actually displayed will
vary based on the browser software you are using.

This sentence is marked with bold and underline to show added text.

This sentence is marked with strikethrough and italic, indicating
text to be removed.

Daily Data Tracking History



H0103.................................................by HEALTH AND WELFARE
CONTROLLED SUBSTANCES - Amends existing law to add the drug carisoprodol to
schedule IV controlled substances.
                                                                        
01/29    House intro - 1st rdg - to printing
01/30    Rpt prt - to Health/Wel

Bill Text


                                                                        
                                                                        
  ||||              LEGISLATURE OF THE STATE OF IDAHO             ||||
 Fifty-sixth Legislature                  First Regular Session - 2001
                                                                        
                                                                        
                              IN THE HOUSE OF REPRESENTATIVES
                                                                        
                                     HOUSE BILL NO. 103
                                                                        
                              BY HEALTH AND WELFARE COMMITTEE
                                                                        
  1                                        AN ACT
  2    RELATING TO CONTROLLED SUBSTANCES; AMENDING SECTION 37-2711,  IDAHO  CODE,  TO
  3        ADD THE DRUG CARISOPRODOL TO SCHEDULE IV CONTROLLED SUBSTANCES.
                                                                        
  4    Be It Enacted by the Legislature of the State of Idaho:
                                                                        
  5        SECTION  1.  That  Section 37-2711, Idaho Code, be, and the same is hereby
  6    amended to read as follows:
                                                                        
  7        37-2711.  SCHEDULE IV. (a) Schedule IV shall  consist  of  the  drugs  and
  8    other  substances,  by  whatever official name, common or usual name, chemical
  9    name, or brand name designated, listed in this section.
 10        (b)  Narcotic drugs. Unless specifically  excepted  or  unless  listed  in
 11    another  schedule,  any material, compound, mixture, or preparation containing
 12    any of the following narcotic drugs, or their salts  calculated  as  the  free
 13    anhydrous base or alkaloid, in limited quantities as set forth below:
 14        (1)  No more than 1 milligram of difenoxin and not less than 25 micrograms
 15        of atropine sulfate per dosage unit;
 16        (2)  Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,
 17        2-diphenyl-3-methyl-2-propionoxybutane).
 18        (c)  Depressants. Unless specifically excepted or unless listed in another
 19    schedule,  any  material, compound, mixture, or preparation which contains any
 20    quantity of the following substances, including its salts, isomers, and  salts
 21    of isomers whenever the existence of such salts, isomers, and salts of isomers
 22    is possible within the specific chemical designation:
 23        (1)  Alprazolam;
 24        (2)  Barbital;
 25        (3)  Bromazepam;
 26        (4)  Camazepam;
 27        (5)  Chloral betaine;
 28        (6)  Chloral hydrate;
 29        (7)  Chlordiazepoxide;
 30        (8)  Clobazam;
 31        (9)  Clonazepam;
 32        (10) Clorazepate;
 33        (11) Clotiazepam;
 34        (12) Cloxazolam;
 35        (13) Delorazepam;
 36        (14) Diazepam;
 37        (15) Estazolam;
 38        (16) Ethchlorvynol;
 39        (17) Ethinamate;
 40        (18) Ethyl loflazepate;
 41        (19) Fludiazepam;
 42        (20) Flurazepam;
 43        (21) Halazepam;
                                                                        
                                           2
                                                                        
  1        (22) Haloxazolam;
  2        (23) Ketazolam;
  3        (24) Loprazolam;
  4        (25) Lorazepam;
  5        (26) Lormetazepam;
  6        (27) Mebutamate;
  7        (28) Medazepam;
  8        (29) Meprobamate;
  9        (30) Methohexital;
 10        (31) Methylphenobarbital (mephobarbital);
 11        (32) Midazolam;
 12        (33) Nimetazepam;
 13        (34) Nitrazepam;
 14        (35) Nordiazepam;
 15        (36) Oxazepam;
 16        (37) Oxazolam;
 17        (38) Paraldehyde;
 18        (39) Petrichloral;
 19        (40) Phenobarbital;
 20        (41) Pinazepam;
 21        (42) Prazepam;
 22        (43) Temazepam;
 23        (44) Tetrazepam;
 24        (45) Triazolam;
 25        (46) Quazepam;
 26        (47) Zolpidem.
 27        (d)  Fenfluramine  - Any material, compound, mixture, or preparation which
 28    contains any quantity  of  the  following  substances,  including  its  salts,
 29    isomers  (whether optical, position, or geometric), and salts of such isomers,
 30    whenever the existence of such salts, isomers, and salts of isomers is  possi-
 31    ble:
 32        (1)  Fenfluramine.
 33        (e)  Stimulants.  Unless specifically excepted or unless listed in another
 34    schedule, any material, compound, mixture, or preparation which  contains  any
 35    quantity  of the following substances having a stimulant effect on the central
 36    nervous system, including its salts, isomers (whether  optical,  position,  or
 37    geometric),  and  salts  of such isomers whenever the existence of such salts,
 38    isomers, and salts of isomers is possible within the specific chemical  desig-
 39    nation:
 40        (1)  Cathine ((+)-norpseudoephedrine);
 41        (2)  Diethylpropion;
 42        (3)  Fencamfamin;
 43        (4)  Fenproporex;
 44        (5)  Mazindol;
 45        (6)  Mefenorex;
 46        (7)  Pemoline (including organometallic complexes and chelates thereof);
 47        (8)  Phentermine;
 48        (9)  Pipradrol;
 49        (10) Sibutramine;
 50        (11) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
 51        (f)  Other  substances.  Unless specifically excepted, or unless listed in
 52    another schedule, any material, compound, mixture or  preparation  which  con-
 53    tains any quantity of the following substances, including its salts:
 54        (1)  Pentazocine;
 55        (2)  Carisoprodol.
                                                                        
                                           3
                                                                        
  1        (g)  The  board  may  except by rule any compound, mixture, or preparation
  2    containing any depressant substance listed in subsection (c) of  this  section
  3    from  the application of all or any part of this act if the compound, mixture,
  4    or preparation contains one (1) or more active medicinal ingredients not  hav-
  5    ing  a  depressant effect on the central nervous system, and if the admixtures
  6    are included therein in combinations, quantity, proportion,  or  concentration
  7    that vitiate the potential for abuse of the substances which have a depressant
  8    effect on the central nervous system.

Statement of Purpose / Fiscal Impact


                   STATEMENT OF PURPOSE
                             
                         RS 10662
                             
The purpose of this proposed legislation is to add the drug
carisoprodol to Schedule IV of the controlled substance act
making it a felony to obtain this drug by misrepresentation,
fraud, forgery, deception or subterfuge. It would also restrict
prescriptions for this drug to five refills or six months and
automatically add it to our controlled substance tracking system.
This change is in response to the continued diversion and abuse
of this drug.




                       FISCAL IMPACT
                             
                             
                             
There will be no fiscal on the General Fund, no cost to the
general public or practitioners, and implementation of
legislation will be from the Board of Pharmacy dedicated funds.



STATEMENT OF PURPOSE/FISCAL NOTE                         H 103
      





Contact
            Name:     Richard K. "Mick" Markuson, Executive Director
      Idaho State Board of Pharmacy
            Phone:
                 (208)334 2356
                          STATEMENT OF PURPOSE
                              
                          RS 10759
                              
To increase the grocery tax credit to $50.00 for the
calendar year 2001 and repeal sales tax on "food" beginning July
1, 2002. When sales tax is removed from food, the increased
grocery tax credit would be repealed. The definition for "food"
would be the same as for food stamps.




                       FISCAL IMPACT
                              
                              
                              
Increasing the grocery tax credit would have projected
general fund impact of $18.6 Million for fiscal year 2002.
Subsequently repealing sales tax on "food" and repealing the
increased grocery tax credit would have a projected net general
fund impact of $84,908,808 in fiscal year 2003.











Contact
            Name:     Rep. Bill Sali
                  Phone:
                 332 1000
                           STATEMENT OF PURPOSE
                               
                           RS 10748
                               
To double the grocery tax credit for the calendar
and repeal sales tax on "food" beginning July 1, 2002.
sales tax is removed from food, the grocery tax credit
repealed. The definition for "food" would be the same food
stamps.




                            FISCAL
                            IMPACT
year 2001
When

would be
as for



Doubling the grocery tax credit would have projected general fund
impact of $18.6 Million for fiscal year 2002. Subsequently repealing
sales tax on "food" and repealing the increased grocery tax credit
would have a projected net general fund impact of $84,908,808 in fiscal
year 2003.












Contact
            Name:     Rep. Bill Sali
                  Phone:    332 1000